Technical Analysis for PRPH - ProPhase Labs, Inc.

Grade Last Price % Change Price Change
F 0.77 0.66% 0.01
PRPH closed up 0.66 percent on Wednesday, November 20, 2024, on 35 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.66%
Wide Bands Range Expansion 0.66%
Oversold Stochastic Weakness 0.66%
Narrow Range Bar Range Contraction -2.84%
Wide Bands Range Expansion -2.84%
Oversold Stochastic Weakness -2.84%

   Recent Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ProPhase Labs, Inc. Description

ProPhase Labs, Inc. engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public. It is also involved in the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care, and cosmeceutical products. The company offers Cold-EEZE, a zinc gluconate glycine lozenge to reduce the duration and severity of the common cold symptoms. It also markets and distributes two non-lozenge forms of its proprietary zinc gluconate formulation, Cold-EEZE daytime/nighttime QuickMelts and Cold-EEZE oral spray; and Kids-EEZE products for children suffering from upper respiratory infections, allergy, and/or chest congestion, as well as organic cough drops and a Vitamin C supplements. It also provides private label lozenge products for retail customers; and performs contract manufacturing services of cough drop and other OTC cold remedy products for third parties. ProPhase Labs, Inc. sells its products through food, multi-outlet pharmacy and chain drug stores, wholesalers, and mass merchandisers in the United States. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Vitamins Health Products Dietary Supplement Allergy Zinc Contract Manufacturing Contract Manufacturing Services Cough Over The Counter Drug Respiratory Infection Upper Respiratory Infection

Is PRPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.48
52 Week Low 0.6601
Average Volume 127,890
200-Day Moving Average 3.83
50-Day Moving Average 2.04
20-Day Moving Average 1.53
10-Day Moving Average 0.83
Average True Range 0.17
RSI (14) 18.70
ADX 55.52
+DI 5.40
-DI 43.53
Chandelier Exit (Long, 3 ATRs) 1.94
Chandelier Exit (Short, 3 ATRs) 1.17
Upper Bollinger Bands 2.97
Lower Bollinger Band 0.09
Percent B (%b) 0.24
BandWidth 188.68
MACD Line -0.44
MACD Signal Line -0.37
MACD Histogram -0.0668
Fundamentals Value
Market Cap 13.8 Million
Num Shares 18 Million
EPS -0.63
Price-to-Earnings (P/E) Ratio -1.21
Price-to-Sales 1.49
Price-to-Book 1.68
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.83
Resistance 3 (R3) 0.82 0.80 0.82
Resistance 2 (R2) 0.80 0.78 0.80 0.82
Resistance 1 (R1) 0.78 0.77 0.79 0.79 0.81
Pivot Point 0.75 0.75 0.76 0.76 0.75
Support 1 (S1) 0.74 0.74 0.75 0.74 0.72
Support 2 (S2) 0.71 0.73 0.71 0.71
Support 3 (S3) 0.69 0.71 0.71
Support 4 (S4) 0.70